← Back to Search
Mitochondrial DNA Depletion In Respiratory Chain–Deficient Parkinson Disease Neurons
A. Grünewald, K. Rygiel, P. Hepplewhite, C. Morris, M. Picard, D. Turnbull
Published 2016 · Medicine, Biology
Download PDFAnalyze on Scholarcy
To determine the extent of respiratory chain abnormalities and investigate the contribution of mtDNA to the loss of respiratory chain complexes (CI–IV) in the substantia nigra (SN) of idiopathic Parkinson disease (IPD) patients at the single‐neuron level.
This paper references
MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's disease
D. Galter (2010)
The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes.
H. Schägger (2001)
Mechanism of mammalian mitochondrial DNA replication: import of mitochondrial transcription factor A into isolated mitochondria stimulates 7S DNA synthesis.
S. Gensler (2001)
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Mats I Ekstrand (2007)
A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells.
K. J. Krishnan (2007)
1‐Methyl‐4‐phenylpyridinium ion, a toxin that can cause parkinsonism, alters branched structures of DNA
M. Iwaasa (2002)
Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.
Jin-qiang Chen (2009)
Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation
Huu B. Ngo (2014)
Mitochondrial transcription factor A regulates mtDNA copy number in mammals.
Mats I Ekstrand (2004)
Mitochondrial pathology in Parkinson's disease.
A. Schapira (2011)
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
A. Bender (2006)
The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons
A. Reeve (2013)
Relative abundance of the human mitochondrial transcription system and distinct roles for h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene expression
Justin L Cotney (2007)
Molecular Pathogenesis of Polymerase Gamma–Related Neurodegeneration
C. Tzoulis (2014)
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.
M. D. de Rijk (1997)
and h-mtTFB2 in mitochondrial biogenesis and gene expression
In D-loop: 40years of mitochondrial 7S DNA
T. Nicholls (2014)
Stages in the development of Parkinson’s disease-related pathology
H. Braak (2004)
Resistance training in patients with single, large-scale deletions of mitochondrial DNA.
J. Murphy (2008)
Transcription and replication of mitochondrial DNA.
D. Clayton (2000)
Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis.
N. Bellance (2009)
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease
N. Hattori (1991)
Axial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis
A. Hiniker (2014)
Structure of human mitochondrial RNA polymerase
R. Ringel (2011)
Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue
A. Grünewald (2014)
Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons.
A. Reeve (2012)
Parkinson's disease and parkinsonism: neuropathology.
D. Dickson (2012)
Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
N. Lax (2016)
Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
A. Rakovic (2010)
The D-loop structure of human mtDNA is destabilized directly by 1-methyl-4-phenylpyridinium ion (MPP+), a parkinsonism-causing toxin.
S. Umeda (2000)
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
A. Schapira (1989)
Genetics of Parkinson's disease
Tim Postmus (2018)
Control of Mitochondrial Transcription Specificity Factors (TFB1M and TFB2M) by Nuclear Respiratory Factors (NRF-1 and NRF-2) and PGC-1 Family Coactivators
N. Gleyzer (2005)
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J. Langston (1983)
Medicine and the law. Consent to medical treatment in prison.
D. Brahams (1983)
Release of replication termination controls mitochondrial DNA copy number after depletion with 2',3'-dideoxycytidine.
T. Brown (2002)
Respiratory chain protein turnover rates in mice are highly heterogeneous but strikingly conserved across tissues, ages, and treatments
P. Karunadharma (2015)
Mitochondrial DNA Rearrangements in Health and Disease—A Comprehensive Study
Joana Damas (2014)
TFAM forces mtDNA to make a U-turn
B. Hallberg (2011)
Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance
C. R. Arthur (2009)
Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number.
C. Campbell (2012)
Parkinson ’ s disease and parkinsonism : neuropathol
DW Dickson (2012)
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons
Y. Kraytsberg (2006)
Triplex real-time PCR–an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells
K. Rygiel (2015)
This paper is referenced by
Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease
Alexander Bury (2017)
Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
Rafael Franco (2020)
Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy”
G. Dalla Costa (2019)
Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease
Hannah Lowes (2020)
Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson’s Disease Mouse Model
Dongsoo Kim (2016)
Mitochondrial DNA Deletions Discriminate Affected from Unaffected LRRK2 Mutation Carriers
Nassima Ouzren (2019)
Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation
Eldris Iglesias (2019)
Neuronal Mitophagy: Lessons from a Pathway Linked to Parkinson’s Disease
O. Corti (2019)
Parkinson’s Disease: Insights from Drosophila Model
Mohamad Ayajuddin (2018)
Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
P. Podlesniy (2019)
Single Cell Neurometabolomics.
Meng Qi (2018)
Increased Degradation Rates in the Components of the Mitochondrial Oxidative Phosphorylation Chain in the Cerebellum of Old Mice
A. Popa-Wagner (2018)
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol
Vanessa Kappel da Silva (2018)
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xian-Si Zeng (2018)
Alteration of Gene Associated with Retinoid-interferon-induced Mortality-19-expressing Cell Types in the Mouse Hippocampus Following Pilocarpine-induced Status Epilepticus
Jae-Cheon Kim (2020)
Molecular mechanisms of autophagy and the effect of autophagy dysfunction on mitochondrial function
Elsje G. Otten (2017)
DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions
L. Caporali (2018)
Mitochondria in the pathophysiology of Alzheimer's and Parkinson's diseases.
I. Onyango (2017)
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
L. Yang (2020)
New insights into the complex role of mitochondria in Parkinson’s disease
A. Grünewald (2018)
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.
M. Mattson (2018)
Mitochondrial DNA heteroplasmy rises in substantial nigra of aged PINK1 KO mice.
J. Li (2019)
Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease
Milena Pinto (2018)
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
Anne-Laure Mahul-Mellier (2020)
GDF‐15 promotes mitochondrial function and proliferation in neuronal HT22 cells
H. Liu (2019)
Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder
Carl Morén (2017)
Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo
Hefeng Zhou (2019)
Increased energetic demand supported by mitochondrial electron transfer chain and astrocyte assistance is essential to maintain the compensatory ability of the dopaminergic neurons in an animal model of early Parkinson's disease.
K. Kuter (2018)
Two Distinct De novo Pathogenic Sequence Variants in the SCN2A Gene in Children with Early Infantile Epileptic Encephalopathy/Ohtahara Syndrome
Marketa Wayhelova (2017)
Heterogeneity of GRIM-19 Expression in the Adult Mouse Brain
Sun-Nyoung Hwang (2019)
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge (2020)
Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues
C. Chen (2020)See more